Road to AgSuccess?

Rosetta Green, an Israeli biotech company focused on uncovering genes that can be used to improve agricultural and biofuel crops, has been bought by Monsanto fro $35 million, reports Bioentrepreneur's Trade Secrets blog. Rosetta Green was a spinoff from Rosetta Genomics.

This, writes Bernard Dichek at Trade Secrets, could be the beginning of a trend.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in PNAS

Still Concerns

This Week in PLOS

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.